Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium studyWeiva Sieh, Marcus Q. Bernardini, Martin Köbel et al.|The Lancet Oncology|2013Cited by 434
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studyAnna DeFazio, Martin Köbel, Jason Madore et al.|British Journal of Cancer|2014Cited by 113
The onset location of multiple sclerosis predicts the location of subsequent relapsesEllen M. Mowry, E. Waubant, Suha Deen et al.|Journal of Neurology Neurosurgery & Psychiatry|2008Cited by 51
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesEun Young Kang, P. Mackenzie, Dane Cheasley et al.|Modern Pathology|2020Cited by 43
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium studyMartin Köbel, Jaime Lesnock, Jennifer Alsop et al.|The Journal of Pathology Clinical Research|2023Cited by 29